Vixiar Medical Receives BioMaryland Development Award

Vixiar Medical, Inc. announced today that it was awarded a $200,000 grant by the State of Maryland to accelerate the commercialization of its non-invasive congestive heart failure (CHF) device. The BioMaryland Center made the awards on a competitive basis to six life sciences companies, with preference given to projects that improve patient outcomes and reduce health care costs.

Read more: PRWeb